Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Iron polymaltose complex + folic acid is an oral combination therapy used for the prevention and treatment of iron deficiency anemia, particularly during pregnancy and the postpartum period. Iron polymaltose complex (IPC) is a non-ionic complex of iron(III) hydroxide and polymaltose, which provides a stable, highly bioavailable source of iron with fewer gastrointestinal side effects compared to traditional ferrous salts. Folic acid (Vitamin B9) is included to support erythropoiesis and DNA synthesis, helping to prevent megaloblastic anemia and neural tube defects. This combination is frequently used in maternal health to maintain hemoglobin levels and replenish iron stores.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on iron polymaltose complex + folic acid.